Gå till sökfältet
Gå till sidans huvudinnehåll
Gå till tillgänglighetsredogörelsen
Forskning.fi
Menu
Suomeksi
På svenska
In English
Ingångssida
Sökning
Vetenskaps- och innovationspolitik
Vetenskaps- och forskningsnyheter
På svenska
- 16802 results
Publikationer
16802
Utlysningar
0
Beviljade finansiering
59
Personer
4
Data
8
Infrastrukturer
3
Organisationer
0
Projekt
0
Publikationer -
16 802
sökresultat
Gå till sökresultaten
Visa som bild
Begränsa sökning
Resultaten visas 1 - 10 / 16802
10
50
100
resultat / per sida
Vilka
publikations
uppgifter finns i tjänsten?
Icon
Publikationens namn
Upphovspersoner
Publikationskanal
År
Publicationer information ikon
Discovery and Structural Characterization of a Phospholamban-Binding Cyclic Peptide and
Design
of Novel Inhibitors of Phospholamban
Referentgranskad
DOI
10.1111/j.1747-0285.2012.01409.x
Tilgmann, Carola; Pollesello, Piero; Ovaska, Martti; Kaivola, Juha; Pystynen, Jarmo; Tiainen, Eija; ...
Chemical Biology and
Drug
Design
(Print)
2013
Publicationer information ikon
Marine alkaloid oroidin analogues with antiviral potential: a novel class of synthetic compounds targeting the cellular chaperone Hsp90
Referentgranskad
Öppen tillgång
DOI
10.1111/cbdd.13034
Lillsunde, Katja-Emilia ; Tomašič, Tihomir; Kikelj, Danijel; Tammela, Päivi
Chemical Biology and
Drug
Design
(Print)
2017
Publicationer information ikon
Inhibition of Human CYP1 Enzymes by a Classical Inhibitor α-Naphthoflavone and a Novel Inhibitor N-(3, 5- Dichlorophenyl)cyclopropanecarboxamide - An in Vitro and in Silico Study
Referentgranskad
Öppen tillgång
DOI
10.1111/cbdd.13669
Risto Olavi Juvonen, Elmeri Matias Jokinen, Adeel Javaid, Marko Lehtonen, Hannu Raunio, Olli Taneli ...
chemical biology
drug
design
2020
Publicationer information ikon
A novel alpha-amylase inhibitor-based spirooxindole-pyrrolidine-clubbed thiochromene-pyrzaole pharmacophores : Unveiling the [3+2] cycloaddition reaction by molecular electron density theory
Referentgranskad
DOI
10.1111/cbdd.14299
Islam, Mohammad Shahidul; Al‐Majid, Abdullah Mohammed; Haukka, Matti; Parveen, Zahida; Ravaiz, Nabee...
Chemical Biology and
Drug
Design
2023
Publicationer information ikon
Suitability of MMGBSA for the selection of correct ligand binding modes from docking results
Referentgranskad
Öppen tillgång
DOI
10.1111/cbdd.13446
Ahinko, Mira; Niinivehmas, Sanna; Jokinen, Elmeri; Pentikäinen, Olli
Chemical biology and
drug
design
2019
Publicationer information ikon
Fragment‐ and Negative Image‐Based Screening of Phosphodiesterase 10A Inhibitors
Referentgranskad
Öppen tillgång
DOI
10.1111/cbdd.13584
Jokinen, Elmeri M.; Postila, Pekka A.; Ahinko, Mira; Niinivehmas, Sanna; Pentikäinen, Olli T.
Chemical biology and
drug
design
2019
Publicationer information ikon
Evaluation of the antitumor activity of NOV202, a novel microtubule targeting and vascular disrupting agent
Referentgranskad
Öppen tillgång
DOI
10.2147/DDDT.S133189
Rickardson L, Kutvonen E, Orasniemi S, Hogberg M, Kallio MJ, Rehnmark S
Drug
Design
, Development and Therapy
2017
Publicationer information ikon
Evaluation of the efficacy and safety of three dosing regimens of agalsidase alfa enzyme replacement therapy in adults with Fabry disease
Referentgranskad
Öppen tillgång
Gol\303\241\305\210 L, Goker-Alpan O, Holida M, Kantola I, Klopotowski M, Kuusisto J, Linhart A, Mus...
Drug
design
development and therapy
2015
Publicationer information ikon
Evaluation of the efficacy and safety of three dosing regimens of agalsidase alfa enzyme replacement therapy in adults with Fabry disease.
Referentgranskad
Golán L; Goker-alpan O; Holida M; Kantola I ; et all.
Drug
Design
, Development And Therapy
2015
Publicationer information ikon
Evaluation of the efficacy and safety of three dosing regimens of agalsidase alfa enzyme replacement therapy in adults with Fabry disease
Referentgranskad
Golán L; Goker-Alpan O; Holida M; Kantola I; Klopotowski M; Kuusisto J; Linhart A; Musial J; Nicholl...
Drug
Design
, Development And Therapy
2015
Discovery and Structural Characterization of a Phospholamban-Binding Cyclic Peptide and
Design
of Novel Inhibitors of Phospholamban
Referentgranskad
DOI
10.1111/j.1747-0285.2012.01409.x
2013
Marine alkaloid oroidin analogues with antiviral potential: a novel class of synthetic compounds targeting the cellular chaperone Hsp90
Referentgranskad
Öppen tillgång
DOI
10.1111/cbdd.13034
2017
Inhibition of Human CYP1 Enzymes by a Classical Inhibitor α-Naphthoflavone and a Novel Inhibitor N-(3, 5- Dichlorophenyl)cyclopropanecarboxamide - An in Vitro and in Silico Study
Referentgranskad
Öppen tillgång
DOI
10.1111/cbdd.13669
2020
A novel alpha-amylase inhibitor-based spirooxindole-pyrrolidine-clubbed thiochromene-pyrzaole pharmacophores : Unveiling the [3+2] cycloaddition reaction by molecular electron density theory
Referentgranskad
DOI
10.1111/cbdd.14299
2023
Suitability of MMGBSA for the selection of correct ligand binding modes from docking results
Referentgranskad
Öppen tillgång
DOI
10.1111/cbdd.13446
2019
Fragment‐ and Negative Image‐Based Screening of Phosphodiesterase 10A Inhibitors
Referentgranskad
Öppen tillgång
DOI
10.1111/cbdd.13584
2019
Evaluation of the antitumor activity of NOV202, a novel microtubule targeting and vascular disrupting agent
Referentgranskad
Öppen tillgång
DOI
10.2147/DDDT.S133189
2017
Evaluation of the efficacy and safety of three dosing regimens of agalsidase alfa enzyme replacement therapy in adults with Fabry disease
Referentgranskad
Öppen tillgång
2015
Evaluation of the efficacy and safety of three dosing regimens of agalsidase alfa enzyme replacement therapy in adults with Fabry disease.
Referentgranskad
2015
Evaluation of the efficacy and safety of three dosing regimens of agalsidase alfa enzyme replacement therapy in adults with Fabry disease
Referentgranskad
2015
Föregående
1
2
3
4
5
Nästa
Resultaten visas 1 - 10 / 16802
Sida 1
Sort
